v3.26.3
Shareholders' Equity And Earnings Per Share - Schedule of Weighted Average Number of Shares (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Numerator:        
Net income attributable to Versigent $ 102 $ 109 $ 298 $ 311
Denominator:        
Weighted average ordinary shares outstanding, basic (in shares) 70,850 70,890 70,880 70,890
Dilutive shares related to restricted stock units (in shares) 1,400 0 790 0
Weighted average ordinary shares outstanding, including dilutive shares (in shares) 72,250 70,890 71,670 70,890
Earnings per share attributable to Versigent:        
Basic (in usd per share) $ 1.44 $ 1.54 $ 4.20 $ 4.39
Diluted (in usd per share) $ 1.41 $ 1.54 $ 4.16 $ 4.39